ABSTRACT Antiviral activity of rabbit and mouse fibroblast interferons was irreversibly destroyed by treatment with halomethyl ketone derivatives of phenylalanine but not by treatment with a halomethyl ketone derivative of lysine. The inactivation reaction was pH dependent, suggesting the involvement of an amino acid residue ionizing in the region ofpH 7. Tryptophan and phenylalanine, known ligands of interferons, protected rabbit interferon substantially against inactivation by the chloromethyl ketone derivative ofN-tosylphenylalanine. Mixed bovine brain gangliosides protected rabbit and mouse interferons against inactivation by this reagent. Although halomethyl ketone derivatives of phenylalanine were originally designed and used for affinity labeling ofthe active site ofchymotrypsin and similar enzymes, no evidence was found for a chymotrypsin-like activity ofinterferons. It is proposed that halomethyl ketone derivatives of phenylalanine inactivate interferon by an affinity labeling mechanism, first binding to a hydrophobic binding site and then reacting irreversibly with a nearby nucleophilic amino acid residue, which appears to be a histidine. This conclusion implies that a hydrophobic site on interferons is necessary for their antiviral activity. Interferons are also known to bind to various ligands, including aromatic amino acids, anionic polyaromatic dyes, polyribonucleotides, and gangliosides (1). It has been suggested that the binding of gangliosides takes place at a site on the interferon molecule involved in binding to the cell surface (2). The biological significance ofthe other ligand affinities ofinterferons is not clear.
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Interferons are proteins secreted by animal cells in response to virus infection or other stimuli. They are capable of binding to cells and inducing a state in which the cells do not support virus replication.
Interferons are also known to bind to various ligands, including aromatic amino acids, anionic polyaromatic dyes, polyribonucleotides, and gangliosides (1) . It has been suggested that the binding of gangliosides takes place at a site on the interferon molecule involved in binding to the cell surface (2) . The biological significance ofthe other ligand affinities ofinterferons is not clear.
We have recently presented evidence that the binding offibroblast interferons to hydrophobic ligands, especially aromatic substances, may reflect a hydrophobic binding site essential for antiviral activity. This suggestion was based on our finding that tryptophan, a known ligand of interferons (3), protects mouse and rabbit fibroblast interferons (MuIFN and RaIFN, respectively) against the arginine-specific reagent butanedione (4) . As an extension of this work, we have now applied the technique ofaffinity labeling (5) using molecules containing a moiety able to bind hydrophobically to interferons and a moiety able to react with nearby nucleophilic amino acid side chains. In this paper, we report the specific inactivation of RaIFN and MuIFN by halomethyl ketone derivatives of phenylalanine. This inactivation has been characterized, and evidence is presented that the reagents attach to a hydrophobic binding site by an affinity labeling mechanism and that the inactivation is due to a specific modification of histidine residues. Since these phenylalanine derivatives were originally designed to be active-site reagents for chymotrypsin and related enzymes (6), attempts were made to test the possibility that interferons are proteases similar to chymotrypsin.
MATERIALS AND METHODS Chemicals. Nc-Tosyl-L-phenylalanine chloromethyl ketone (Tos-LysCH2CI), Na-tosyl-L-lysine chloromethyl ketone (TosPheCH2Cl), Na-carbobenzoxy-L-phenylalanine chloromethyl ketone (Cbz-PheCH2CI), diisopropyl fluorophosphate, and cytochrome c were purchased from Serva Biochemicals (Heidelberg, Federal Republic of Germany). Na-Carbobenzoxy-Lphenylalanine bromomethyl ketone (Cbz-PheCH2Br) was obtained from' Nutritional Biochemicals. Phenylmethylsulfonyl fluoride and mixed bovine brain gangliosides, type III, were from Sigma. L-Tryptophan, L-phenylalanine, and bromoacetic acid were Merck products. Iodoacetic acid from Fluka was recrystallized three times before use. Poly(I) and poly(I-C) were Boehringer Mannheim products.
Interferons. Rabbit interferon was prepared by inducing primary rabbit kidney cultures with poly(I-C) using a superinduction schedule as described (7) Abbreviations: Tos-PheCH2Cl, Na-tosyl-L-phenylalanine chloromethyl ketone; Tos-LysCH2Cl, Na-tosyl-L-lysine chloromethyl ketone; CbzPheCH2CI, Na-carbobenzoxy-L-phenylalanine chloromethyl ketone; Cbz-PheCH2Br, Nacarbobenzoxy-L-phenylalanine bromomethyl ketone; RaIFN, rabbit fibroblast interferon; MuIFN, mouse fibroblast interferon. 4829 The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
Inactivation Procedures. All inactivation reactions were done in 1.5-ml Eppendorf reaction tubes with total volumes of 0.05 ml in most experiments and 0.1 ml in the others. The alkylating reagents were dissolved in methanol just before use. Generally, the reaction mixtures were constituted as follows: 1 vol of interferon, 1 vol of buffer, 0.25 or 0.5 vol of alkylating reagent and, when appropriate, 0.25vol of water or methanol. The buffer used was normally 0.5 M sodium phosphate (pH 8.0). In some experiments, 0.1 M sodium phosphate (pH 8.0) or 0.02 M barbital, pH 8.0/0.15 M NaCI was used. The final concentration ofmethanol in the incubation mixtures was 10% or 20%. After mixing, the reaction mixtures were incubated at 370C. Although we initially stopped the reactions by adding excess dithioerythritol, we found that simple cooling in an ice-water bath and immediate assay were just as effective. In all experiments reported here the values given are relative to controls, which were treated exactly like the experimental samples except for the lack of inactivation reagent.
In all inactivation experiments with RaIFN, the crude concentrated dialyzed material was diluted 1:1 or 1:4 with water before use. All incubation mixtures for inactivation of MuIFN contained cytochrome c at 1 mg/ml as a stabilizing agent.
In protection experiments, reaction mixtures containing all components except for chloromethyl ketone were first incubated at 370C for 10 min and then treated with Tos-PheCH2Cl, mixed, and incubated as described above. RESULTS Inactivation of Interferons by Halomethyl Ketone Derivatives of Phenylalanine. Initial experiments showed that TosPheCH2Cl, but not Tos-LysCH2CI, progressively inactivated crude RaIFN. This inactivation was slow, requiring :20 hr of incubation at 37C with 1 mM Tos-PheCH2C1 for 80-90% inactivation. However, it could be shown that the incubation time necessary for nearly complete inactivation was drastically decreased if, before Tos-PheCH2Cl treatment, the diluted RaIFN was incubated at 370C overnight. Control experiments indicated that no loss of antiviral activity occurred on incubation without Tos-PheCH2CI. The nature of this activation phenomenon is not clear. MuIFN did not require prior incubation to obtain rapid inactivation by halomethyl ketone derivatives of phenylalanine.
With previously incubated RaIFN, inactivation by 1 mM TosPheCH2Cl was rapid; 80-90% inactivation was achieved within 2 hr at 370C (Fig. 1) . In contrast to the effect of Tos-PheCH2Cl, there was no significant inactivation ofRaIFN by Tos-LysCH2Cl during a 2-hr incubation at 37°C. This type of experiment has been repeated several times with similar results.
Inactivation of RaIFN by Tos-PheCH2Cl was concentration dependent (Fig. 2) . Included in this figure are data from a similar experiment showing that identical concentrations of TosLysCH2Cl did not affect the antiviral activity of RaIFN under these conditions. The imprecision of the interferon assay did not allow the type of kinetic analysis essential to demonstrate a saturation effect (5) .
To test the specificity of the alkylating reagents, we have compared the effects ofTos-LysCH2Cl and Tos-PheCH2Cl with those ofthe Tos-PheCH2CI-related compounds Cbz-PheCH2Cl and Cbz-PheCH2Br, as well as two more commonly used alkylating agents, bromoacetic acid and iodoacetic acid. CbzPheCH2C1, which is identical to Tos-PheCH2Cl except for the amino blocking group, and its bromo analogue Cbz-PheCH2Br inactivated RaIFN in a similar manner. In contrast, bromoacetic acid and iodoacetic acid did not inactivate RaIFN under conditions that gave rapid inactivation by Tos-PheCH2Cl (Table 1) .
Partially purified MuIFN was also inactivated specifically by Tos-PheCH2Cl with no significant inactivation by Tos-LysCH2Cl ( Table 1) . As mentioned above, prior incubation was not necessary for rapid inactivation. Cbz-PheCH2CI and Cbz-PheCH2Br also inactivated MuIFN. Cbz-PheCH2Cl was less effective than Tos-PheCH2CI, whereas Cbz-PheCH2Br appeared to be as effective as Tos-PheCH2Cl, consistent with the expected greater reactivity of the bromomethyl ketone group compared with the chloromethyl ketone group. Bromoacetic acid and iodoacetic acid also failed to inactivate MuIFN under these conditions (Table 1) .
pH Dependence of Inactivation. In an attempt to discover the type of amino acid residue modified by the halomethyl ketones of phenylalanine, we studied the pH dependence of the inactivation. Tos-PheCH2Cl inactivation of RaIFN was highly dependent on pH (Fig. 3) . Inactivation was maximal above pH (Fig. 5) , and a number of derivatives of these aromatic amino acids also protected RaIFN significantly against Tos-PheCH2CI inactivation (unpublished data). This protection did not appear to result from reaction ofTos-PheCH2CI with either the amino or the carboxyl group of the amino acids because derivatives in which these groups are blocked, such as tryptophan methyl ester and N-acetyltryptophan, gave similar effects. Mixed brain gangliosides protected RaIFN completely against Tos-PheCH2Cl inactivation, whereas poly(I) was without effect ( Table 2) . Gangliosides appeared to give more complete protection than tryptophan or phenylalanine. Gangliosides, but not poly(I), were also able to protect MuIFN against inactivation by Tos-PheCH2CI (Table 2) .
Bovine serum albumin, another ligand ofinterferons (9, 10), can block Tos-PheCH2CI inactivation of RaIFN Reaction of Interferon with Serine-Specific Inhibitors. Our results suggested the possibility that interferons might be-chymotrypsin-like enzymes. If this is true, interferons should be inactivated by inhibitors of serine proteases. We have confirmed and extended the results of Merigan et aL (11) with chicken interferon by showing that diisopropyl fluorophosphate and phenylmethylsulfonyl fluoride do not inactivate RaIFN either with or without prior incubation at 37TC. In addition, preliminary experiments designed to demonstrate esterase activity in interferon preparations using the 1-naphthyl esters of N-carbobenzoxytryptophan and N-carbobenzoxyphenylalanine (12) as potential substrates were not successful (unpublished data). These results suggest that interferon is not a serine or thiol protease, although the possibility that it is a different type of highly specific protease cannot be excluded. DISCUSSION We propose that halomethyl ketone derivatives of phenylalanine specifically inactivate interferons by an affinity labeling mechanism. Presumably, these compounds first bind to the interferon through their hydrophobic aromatic rings and then react irreversibly, possibly with a nearby histidine imidazole ring, through their reactive halomethyl ketone groups.
Although direct prooffor a specific modification ofinterferon will require peptide mapping and amino acid analysis of interferons inactivated by halomethyl ketone derivatives ofphenylalanine, there is strong, albeit indirect, evidence that such a mechanism underlies the phenomenon we have characterized (6) . These arguments are (i) the specificity of the inactivation, which is mediated by halomethyl ketone derivatives of phenylalanine but not of lysine; (ii) the protection against inactivation conferred by compounds known to bind to a hydrophobic binding site; and (iii) the pH dependence ofthe reaction. The chemical reactivity of the halomethyl ketone group would theoretically permit reaction with any of the different nucleophilic groups in proteins (8) . However, of the potentially reactive amino acid side chains, only imidazole and thiol groups have been shown to react with the phenylalanine halomethyl ketones used in these studies (6, (13) (14) (15) (16) . Thus, rapid modification of cysteine or histidine residues by halomethyl ketones was found to occur in a variety ofserine and thiol proteases (17) . The specificity of this reaction is most striking in the case of trypsin-like and chymotrypsin-like enzymes in which the substrate-related structure of the alkylating reagent determines the rate of inactivation. A similar type of specificity appears to exist for the inactivation of interferon by halomethyl ketones. Only derivatives of phenylalanine that most likely interact with hydrophobic residues in the target protein cause rapid inactivation; an analogous lysine derivative is without effect, even after prolonged incubation. Therefore, we conclude that the rapid inactivation of the interferons by halomethyl ketones is due to specific interactions ofthese reagents with a hydrophobic bind- (21) . The catalytic subunit of cAMP-dependent protein kinase is also inactivated by Tos-PheCH2C1, apparently by an affinity labeling mechanism involving sulfhydryl groups (22) . The general implication of these inactivation experiments is that, in the case of phenylalanine halomethyl ketones and related compounds, the modification usually occurs at a hydrophobic binding site that contains reactive histidine or cysteine residues.
Assuming that our hypothesis is correct, we anticipate that it will be possible to isolate a peptide of interferon that has reacted with the phenylalanine halomethyl ketone. Such a peptide would represent a portion of the interferon amino acid sequence located at or very close to the site(s) involved in hydrophobic binding. Because our results suggest that this hydrophobic binding site is essential for the antiviral activity of interferons, we speculate that isolation or synthesis of this seProc. Nad Acad-. Sci. USA 79 (1982) 
